UBS Group’s Performant Healthcare Inc PHLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-59,943
| Closed | -$463K | – | 11421 |
|
|
2025
Q3 | $463K | Buy |
59,943
+38,136
| +175% | +$243K | ﹤0.01% | 6151 |
|
|
2025
Q2 | $87.2K | Sell |
21,807
-13,529
| -38% | -$38.4K | ﹤0.01% | 7343 |
|
|
2025
Q1 | $105K | Sell |
35,336
-27,296
| -44% | -$70.7K | ﹤0.01% | 7021 |
|
|
2024
Q4 | $189K | Buy |
62,632
+26,325
| +73% | +$90.5K | ﹤0.01% | 6481 |
|
|
2024
Q3 | $136K | Buy |
36,307
+14,709
| +68% | +$50.3K | ﹤0.01% | 6141 |
|
|
2024
Q2 | $62.6K | Sell |
21,598
-47,230
| -69% | -$136K | ﹤0.01% | 6515 |
|
|
2024
Q1 | $202K | Buy |
68,828
+4,529
| +7% | +$12.9K | ﹤0.01% | 5846 |
|
|
2023
Q4 | $201K | Buy |
64,299
+29,740
| +86% | +$77.9K | ﹤0.01% | 5780 |
|
|
2023
Q3 | $78.1K | Sell |
34,559
-4,906
| -12% | -$12.4K | ﹤0.01% | 5998 |
|
|
2023
Q2 | $107K | Buy |
39,465
+39,403
| +63,553% | +$114K | ﹤0.01% | 5966 |
|
|
2023
Q1 | $211 | Buy |
+62
| New | +$203 | ﹤0.01% | 9134 |
|
|
2022
Q3 | – | Sell |
-1,687
| Closed | -$4K | – | 11054 |
|
|
2022
Q2 | $4K | Buy |
+1,687
| New | +$4.19K | ﹤0.01% | 9156 |
|
|
2021
Q3 | – | Sell |
-1,091
| Closed | -$4K | – | 10201 |
|
|
2021
Q2 | $4K | Buy |
+1,091
| New | +$3.1K | ﹤0.01% | 8707 |
|
|
2021
Q1 | – | Sell |
-4,751
| Closed | -$4K | – | 9569 |
|
|
2020
Q4 | $4K | Buy |
4,751
+3,369
| +244% | +$3.44K | ﹤0.01% | 7939 |
|
|
2020
Q3 | $1K | Buy |
1,382
+676
| +96% | +$436 | ﹤0.01% | 7852 |
|
|
2020
Q2 | $0 | Buy |
+706
| New | +$486 | ﹤0.01% | 8436 |
|
|
2019
Q1 | – | Sell |
-2,031
| Closed | -$5K | – | 8260 |
|
|
2018
Q4 | $5K | Buy |
+2,031
| New | +$3.4K | ﹤0.01% | 7568 |
|
|
2018
Q2 | – | Sell |
-4,398
| Closed | -$13K | – | 8317 |
|
|
2018
Q1 | $13K | Buy |
4,398
+1,746
| +66% | +$4.57K | ﹤0.01% | 6729 |
|
|
2017
Q4 | $4K | Buy |
2,652
+1,233
| +87% | +$2.22K | ﹤0.01% | 7480 |
|
|
2017
Q3 | $3K | Sell |
1,419
-2,275
| -62% | -$4.32K | ﹤0.01% | 7410 |
|
|
2017
Q2 | $8K | Buy |
+3,694
| New | +$8.33K | ﹤0.01% | 6932 |
|
|
2017
Q1 | – | Sell |
-3,577
| Closed | -$8K | – | 8051 |
|
|
2016
Q4 | $8K | Buy |
+3,577
| New | +$11.5K | ﹤0.01% | 7049 |
|
|
2016
Q3 | – | Sell |
-3,036
| Closed | -$5K | – | 7984 |
|
|
2016
Q2 | $5K | Buy |
3,036
+226
| +8% | +$385 | ﹤0.01% | 7143 |
|
|
2016
Q1 | $5K | Sell |
2,810
-2,704
| -49% | -$4.69K | ﹤0.01% | 7019 |
|
|
2015
Q4 | $10K | Buy |
5,514
+4,264
| +341% | +$9.71K | ﹤0.01% | 7292 |
|
|
2015
Q3 | $3K | Sell |
1,250
-275
| -18% | -$800 | ﹤0.01% | 7970 |
|
|
2015
Q2 | $5K | Buy |
1,525
+381
| +33% | +$1.19K | ﹤0.01% | 7888 |
|
|
2015
Q1 | $4K | Sell |
1,144
-7,473
| -87% | -$37.9K | ﹤0.01% | 8248 |
|
|
2014
Q4 | $57K | Buy |
+8,617
| New | +$63K | ﹤0.01% | 6331 |
|
Other funds holding PHLT
UBS Group's PHLT Position: Q4 2025 in Review
UBS Group sold out of Performant Healthcare Inc (PHLT) in Q4 2025, closing a stake of 59,943 shares — an estimated $463K sold.
UBS Group first reported a position in PHLT in Q4 2014 and held it in 29 quarters. The position peaked at $463K in Q3 2025. 1 fund tracked by Wall St. Rank holds PHLT as of Q4 2025.
- UBS Group reported no remaining Performant Healthcare Inc position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 59,943 Performant Healthcare Inc shares in Q4 2025, an estimated $463K.
- UBS Group first reported a position in Performant Healthcare Inc in Q4 2014 and held it in 29 quarters.
- UBS Group's Performant Healthcare Inc position peaked at $463K in Q3 2025.
- 1 fund tracked by Wall St. Rank held Performant Healthcare Inc as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.